Report Highlights
The global market for catheters is estimated to increase from $30.8 billion in 2022 to reach $42.5 billion by 2027, at a compound annual growth rate (CAGR) of 6.6% from 2022 through 2027.
Report Includes
- 35 data tables and 34 additional tables
- A detailed review and up-to-date analysis of the global markets for catheters
- Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for catheters, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for global catheters market in USD million values, and corresponding market share analysis by product, application/disease type, and region
- In-depth information (facts and figures) concerning the major market dynamics, technology updates, industry overviews, and competitive environment of the leading market participants
- Review of the international regulatory landscape and the U.S. premarket notifications and approvals for catheters with emphasis on recently approved products as well as products under development or in different stages of clinical trials
- Assessment of the recent U.S. patents and patent applications on the catheters market
- Insight into recent industry structure, current competitive environment, ongoing research (R&D) activities, new product launches, strategic alliances, and company value share analysis based on their segmental revenues
- Detailed company profiles of the leading industry players, including Abbott, B. Braun Melsungen AG, BD, Biotronik, Boston Scientific Corp., Cardinal Health, Edwards Lifesciences Corp., Stryker Corp., and Terumo Corp.
Report Scope
The current report provides an in-depth look at the catheters market. This report analyzes the market trends of catheters with data from 2021, estimates for 2022, projections of compound annual growth rates (CAGRs) through 2027 (forecast period 2022 to 2027), and regional markets for catheters. This report highlights the current and future market potential of catheters along with a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints, and opportunities in the market are covered. The report also covers market projections for 2027 and the market share for key market players.
In this report, the market has been segmented based on product type utilized in the different applications, and by geographic region. Geographic regions covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Individual countries covered include the U.S., Germany, the U.K., Italy, France, Japan, China, and India.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||
Forecast period considered | 2022 to 2027 | ||||||||||||
Base year market size | $29.0 billion | ||||||||||||
Market size forecast | $42.5 billion | ||||||||||||
Growth rate | CAGR of 6.6% for the forecast period of 2022-2027 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Application, By Type, and By Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Report Highlights
The global market for catheters should grow from $27.2 billion in 2018 to $34.5 billion by 2023 at a compound annual growth rate (CAGR) of 4.8% for the period of 2018-2023.
Report Includes
- 19 data tables and 52 additional tables
- Industry analysis of the global catheters’ market
- Analyses of the global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of important segments including cardiovascular, urological, neurovascular, intravenous and specialty catheters
- Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the market
- Information on new products being introduced and their future impact on the market
- A relevant patent analysis
- Profiles of leading manufacturers and suppliers of catheters within the market including, Abbott Laboratories, Boston Scientific Corp., Hollister Inc., Medtronic and Stryker
Report Highlights
The global catheter market has grown to $24.9 billion in 2016 from $23.9 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.7% from 2016 to 2021, reaching nearly $31.3 billion by 2021.
Report Includes
- An overview of the global market for catheters.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of important segments including cardiovascular, urological, neurovascular, intravenous and specialty catheters.
- Help determining the areas of catheter applications poised for growth and the factors driving this growth.
- Information on new products being introduced and their future impact on the market.
- Relevant patent analysis.
- Profiles of leading companies in the catheter industry.
Report Highlights
The global catheter market was nearly $28.6 billion in 2014. This market is expected to grow to $43 billion in 2019, with a compound annual growth rate (CAGR) of 7.1%.
Report Includes
- An overview of the global market for catheters.
- Analyses of global market trends, with data estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Help determining the areas of catheter applications poised for growth and the factors driving this growth
- Information on new products being introduced and their future impact on the market
- Comprehensive profiles of leading companies in the catheter industry.
Report Highlights
The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
Report Highlights
- The global catheter market amounted to $14.5 billion in 2008, and was projected to increase to nearly $18 billion in 2009. It is expected to reach $32.1 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 12.3%.
- The market’s cardiovascular segment is the largest with sales of $6 billion in 2008. That is projected to increase to $7.1 billion in 2009, and to rise at a CAGR of 10.2% to $11.6 billion in 2014.
- The second-largest segment is urology, with revenue of $4.4 billion in 2008, which is expected to reach nearly $6 billion in 2009, and increase to $13.2 billion in 2014, for the highest CAGR among all segments at 17.1%.
Report Highlights
-
The global catheter market is estimated at $13.0 billion for 2007 and forecast to grow at a compound annual growth rate (CAGR) of 8.3% to reach $19.4 billion by 2012.
-
Urologic catheters and diagnostic cardiovascular catheters especially will drive growth within the catheter market.
-
Growth potential in the neurovascular market is strong and waiting to be explored. This market is projected to grow at a CAGR of 9.1% during the forecast period to reach $2.2 billion by 2012.
Report Highlights
-
Fueled by stent revenues, U.S. catheter market sales were forecast to exceed $13.1 billion in 2003. Rising at an AAGR (average annual growthrate) of 12.3%, the market is expected to exceed $23 billion in 2009.
-
Coronary catheter applications should pass $8.2 billion in 2009 with 64% of the projected revenue expected from the sale of drug-elutingstents.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
- U.S. companies received more than 63% of recently granted patents.
Related Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More